Transplant arteriosclerosis (TA) remains the major limitation of long-term graft survival in heart transplantation despite the advances in immunosuppressants. Mesenchymal stem cells (MSCs) have been demonstrated to suppress allogeneic immune responses by numerous in vitro studies. However, the immunomodulatory effects of MSCs in vivo are controversial and the underlying molecular mechanisms are not conclusive. In this study, we investigated the therapeutic potential of autologous bone marrow-derived MSCs on TA in a porcine model of femoral artery transplantation. MSCs or saline were injected into the soft tissue surrounding the arterial grafts immediately postanastomosis. Four weeks after transplantation, neointimal formation increased significantly in untreated allografts compared with the MSC-treated grafts as assessed by intravascular ultrasound (maximum luminal area stenosis: 40 ± 12% vs. 18 ± 6%, p < 0.001). Grafts harvested at 4 weeks showed dense perivascular lymphocyte infiltration accompanied by significant intimal hyperplasia in the untreated but not in the MSC-treated allografts. Serial angiographic examination showed that all of the untreated allografts became occluded at the 8th week whereas the majority of the MSC-treated grafts remained patent at the 12th week posttransplantation (n = 12 each group, p < 0.001). Quantitative PCR analysis revealed that Foxp3 expression was comparable between the untreated and the MSC-treated groups. However, expression of interleukin-10 (IL-10), interferon-γ (IFN-γ), and indoleamine 2,3-dioxygenase (IDO) was increased significantly in the MSC-treated allografts compared with that in the allograft controls (p = 0.021 for IL-10, p = 0.003 for IFN-γ, and p = 0.008 for IDO). In conclusion, local delivery of autologous MSCs alleviates TA by inducing allograft tolerance via enhanced expression of IL-10, IFN-γ, and IDO but not Foxp3-positive cells in the vessel wall. These results suggest that MSCs induce immune tolerance by activating the type 1 regulatory T-like cells.
INTRODUCTION
effective in the treatment of acute rejection to the myocardium of allografts. So far, there is no effective therapy for TA. Once TA complication occurs, a repeat heart trans-Heart transplantation is one of the established treatment modalities for end-stage heart failure. However, the plantation will be necessary, which is costly and limited by the graft availability. Thus, it is important to investi-long-term survival of recipients is limited mainly due to transplant arteriosclerosis (TA), which is characterized gate new strategies for TA therapy in order to improve the survival of heart transplantation recipients. by accelerated concentric intimal hyperplasia diffusely involving the entire coronary vascular bed (15). TA is a Mesenchymal stem cells (MSCs) isolated from bone marrow (BM) are nonhematopoietic stromal cells that chronic inflammatory disease that develops in the setting of conventional immunosuppression regimens that are are able to differentiate into multiple lineages, such as 972 JUI ET AL.
adipocytes, osteocytes, and chondrocytes (19) . In addi-MATERIALS AND METHODS tion to their regenerative potential, BM-derived MSCs Porcine MSC Preparation and Characterization have been demonstrated to suppress immune responses Mononuclear cells were isolated from porcine BM in vitro by inhibiting the proliferation of activated T aspirate by using density gradient centrifugation (Ficollcells, preventing the development of cytotoxic T cells, Paque, GE Healthcare Bio-Sciences AB). After overpromoting the generation of regulatory T cells (Tregs) night incubation, nonadherent cells were washed out (1, 9, 21) , and modulating the maturation or function of with changes of the medium and the attached cells were dendritic cells (DCs) (3) . expanded in MSC medium consisting of α-minimum Multiple potential molecules underlying the immunoessential medium (αMEM, Invitrogen) and 10% fetal suppressive effect of MSCs have been proposed based bovine serum (Invitrogen) supplemented with 10 ng/ml on studies in vitro (26) . MSCs inhibit allogeneic lymbasic fibroblast growth factor and 10 ng/ml epithelial phocyte proliferation by secreting immunosuppressive cell growth factor (R&D). The cells were confirmed as factors including hepatocyte growth factor (HGF), interstem cells by differentiation into adipogenic, osteogenic, leukin-10 (IL-10), prostaglandin E 2 (PGE 2 ), and transand chondrogenic lineages as described previously (19) . forming growth factor-β1 (TGF-β1), or through expression
To trace the injected cells in vivo, one third of MSCs of indoleamine 2,3-dioxygenase (IDO) upon stimulation were labeled with 100 µg/ml of superparamagnetic iron with interferon-γ (IFN-γ) (1, 4, 8, 9, 23) . IDO suppresses oxide (SPIO) particles (Resovist, Schering AG) at T-cell responses and promotes immunological tolerance 37°C overnight. On the day of transplantation, cells via tryptophan depletion and the production of proapowere trypsinized from culture wares, washed with ptotic downstream metabolites (17).
αMEM, and then resuspended in Iscove's modified Dul-It is not entirely clear whether MSCs function in vivo becco's medium (Invitrogen) at a density of 3 × 10 6 /ml. as they do in vitro. The immunosuppressive effect of MSCs has been examined in several rodent models of Flow Cytometry heart transplantation and the results are conflicting.
MSCs isolated from six different animals (passage 3) Intravenous administration of MSCs was reported to were labeled with primary antibodies to cell surface have a modest effect on prolonging graft survival in antigens: CD11R3, CD44, CD45, src-like adaptor I some studies (11,27), and accelerating graft rejection in (SLA I), SLA II (AbD Serotec), CD34 (Santa Cruz Bioothers (14). When combined with low-dose mycophenotechnology), CD90 (Becton Dickinson), CD105 (Abcam), late (20) or rapamycin (11), MSCs seemed to be capable or corresponding isotype controls. Single-color staining of inducing long-term myocardial allograft tolerance, was performed using a fluorescein isothiocyanate-or but not effective in the prevention of TA (20). Morephycoerythrin-conjugated secondary antibody and anaover, MSCs delivered via systemic infusion were found lyzed using a FACS Calibur instrument and with Cell to be only transiently expressed in animal models of car-Quest software (Becton Dickinson). diac transplantation (5, 20) and therefore might have little time to secret immunomodulatory factors. It has been One-Way Mixed Lymphocyte Reaction (MLR) suggested that induction of tolerance in the target tissue of immune damage does not have to be systemic and Peripheral blood mononuclear cells were isolated by gradient centrifugation and contaminating red blood localized therapy may circumvent the requirement for large number of regulatory cells (24) . Thus, local deliv-cells were eliminated using ACK lysing buffer (NH 4 Cl 150 mM, KHCO 3 10 mM, and EDTA 0.01 mM). For ery of immunomodulatory cells may be an alternative to alleviate allograft rejection.
conditioned medium preparation, MSCs autologous to responder were plated at a density of 2 × 10 3 /cm 2 and In the cardiac transplantation model, the therapeutic potential of MSCs on TA and the underlying mecha-grew in MSC medium described above to 50% confluence; the medium was then changed to RPMI-1640 nisms could not be analyzed without the confounding of immunosuppressants that are required to prevent medium (Invitrogen) containing 15% heat-inactivated adult porcine serum (Invitrogen), and culture superna-acute myocardial rejection. Thus, in the present study, we investigated the therapeutic effect of MSCs on TA tant was harvested after 72 h. Prior to the MLR, MSCs and stimulators were rendered mitotically inactive by in a porcine model of femoral artery transplantation without concomitant immunosuppressants. Our results treatment with mitomycin-C (25 µg/ml, Kyowa Hakko Kogyo Co, Ltd.). A coculture was made by mixing 1 × indicate that local administration of autologous MSCs effectively prevents TA through enhanced expres-10 5 stimulator and responder cells per well (1:1) in 96well, round-bottomed plates (Becton Dickinson) in 0.2 sion of IL-10, IFN-γ, and IDO but not forkhead box P3 (Foxp3). ml of RPMI-1640 medium supplemented with 15% heat-inactivated adult porcine serum. For inhibition selective angiography was performed through a 6-F catheter engaged at the external iliac artery upstream to experiments, 5 × 10 4 MSCs or 0.1 ml of conditioned medium were added to the coculture at the beginning of the femoral arterial graft. For IVUS assessment, under the guidance of a 0.014-inch soft wire, the IVUS cathe-the reaction. Each combination of responders and stimulators was run in triplicate, and each responder was set ter (Atlantis TM SRPro 2.5F, 40-MHz, Boston Scientific Corp, Fremont, CA) was advanced so that the IVUS up against autologous simulator as a negative control. On the fourth day of coculture, plates were pulsed with transducer was positioned distal to the arterial graft. The IVUS transducer was pulled back at a constant speed of 1 µCi of [ 3 H]thymidine (PerkinElmer) for a further 18 h. Cells were then harvested and [ 3 H]thymidine incorpo-0.5 mm/s along the length of the vessel to the ostium of common femoral artery. The IVUS records were digi-ration was assessed using a MicroBeta FilterMate-96 Harvester (PerkinElmer) and a 1450 MicroBeta TriLux tized and the maximum area stenosis in the middle of the vascular grafts was analyzed with the resident soft-(PerkinElmer). Proliferation was expressed as the incorporated radioactivity in counts per minutes. ware (Galax system, Boston Scientific Co.) (16).
Pig Model of Femoral Artery Transplantation Magnetic Resonance Imaging (MRI) Analysis
Forty minipigs (20-25 kg) bred in Laboratory Ani-At 3 days and 4 and 12 weeks after cell delivery, mal Center of National Taiwan University were used in MRI scanning was performed on a 1.5-T MR system the study according to the Guidelines for Animal Care.
(Siemens Sonata, Erlangen, Germany). The animals The experimental protocol was approved by the Instiwere examined in the supine position with bilateral tutional Animal Care and Use Committee (approval thighs covered by using a four-element phased-array number 20060178). Animals were initially sedated by surface coil for signal reception. For tracking SPIO parintramuscular injection of Zoletil (5 mg/kg, Virbac Labticles in the lower limbs, images were obtained consecuoratories, France), followed by endotracheal intubation.
tively using an axial T2-weighted fast spin echo Anesthesia was maintained throughout the procedure by angle: 502 ms/9.1 ms/150°; FOV: 300 mm), and an axial was administered intravenously prior to transplantation. T2*-weighted gradient-echo (TR/TE/flip angle: 1170 A 1-cm vascular segment was excised from a femoral ms/22 ms/30°; FOV: 300 mm) sequence. artery of the recipient pig, and then replaced with a 3cm femoral artery segment harvested from the donor Collection of Arterial Graft Specimens pig. Grafts were implanted in an end-to-end fashion Eight (Auto: n = 2, Allo: n = 3, and Allo + MSC: n = anastomosis with continuous 8-0 prolene sutures. The 3) grafts were harvested from the study animals at 4 limb ischemia time was less than 30 min (time from weeks after transplantation for early stage histological clamp to reperfusion) for each extremity. Autologous examination. The remaining grafts (n = 32) were harvested MSCs (3 × 10 6 in 1 ml divided into 10 injections for when they were found to be occluded on angiograms or each graft for Allo + MSC group, n = 15) or saline (1 at the end of the study (12 weeks posttransplantation). ml divided into 10 injections for Allo group, n = 15)
The grafts were cut into 3-mm segments and then snap were injected into the skeletal muscle surrounding the frozen in liquid nitrogen for RNA isolation, or fixed vascular grafts. The incision wound was closed in laywith 10% buffered formalin for histological analysis. ers. Autograft transplantation (Auto group, n = 10) was performed by inserting the femoral artery with a seg-Real-Time Quantitative PCR ment of graft harvested from contralateral femoral artery Total RNA was isolated from graft tissues by homogof the same animal, followed with saline injection. Folenization followed by Trizol extraction (Invitrogen), lowing operation, all animals received oral prophylactic purified by RNeasy Mini Kit (Qiagen), and reversely cephalexin 250 mg/day for 5 days.
transcribed to cDNA using MMLV reverse transcriptase Angiography and Intravascular Ultrasound (IVUS) (Promega). Real-time PCR reactions were performed in triplicates on the Roche LightCycler Instrument 1.5 Graft patency was assessed at the 4th, 8th, and 12th
using LightCycler FastStart DNA Master PLUS SYBR weeks following transplantation by angiography. The Green I kit (Roche) and oligonucleotide primers (Table pigs were anesthetized as described above. A 6-F vascu-1) specific to target genes. The mixture was incubated lar sheath was introduced into the carotid artery and at 95°C for 10 min followed by 40 cycles of 95°C for severity of intimal hyperplasia was calculated by the formula: [(IELA − LA)/IELA] × 100%. For Prussian blue 10 s, 60°C for 15 s, and 72°C for 10 s. Data were analyzed by calculating the crossing point (CP) value, the staining of SPIO particles, tissue sections were incubated with 5% potassium ferrocyanide in 10% hydro-turning point corresponding to the first maximum of the second derivative curve, using the LightCycler3 data chloric acid for 30 min and counterstained with nuclear fast red (Sigma). For immunohistochemical analysis, tis-analysis software. Pig β-actin served as a reference gene. The expression fold of a target gene in the allo-sue sections were subjected to antigen retrieval by heating in 10 mM sodium citrate buffer (pH 7.2) for 10 min graft relative to that in the autograft was calculated by the formula: 2 −∆∆CP where ∆CP = CP target gene − CP β-actin and in a microwave, then treated for 5 min in 3% hydrogen peroxide to block endogenous peroxidase activity. Tis-∆∆CP = ∆CP allograft − ∆CP autograft . sue sections were incubated with antibodies to CD3 Enzyme-Linked Immunosorbent Assay (ELISA) (Vertana), CD14 (Novocastra), CD20, smooth muscle cell αalpha-actin (α-SMA, Dako), collagen type II Serum concentrations of IL-10 and IFN-γ were determined in duplicate with commercially available ELISA (Millipore), IDO (Santa Cruz Biotechnology), IL-10, and IFN-γ (R&D) overnight at 4°C. The application of kits for detection of porcine cytokines (Quantikine Porcine Immunoassays, R&D). The minimum limits of isotype antibodies to tissue sections was used in negative controls. Signals were developed in a 30-min incu-detection were: IL-10, 31 pg/ml and IFN-γ, 39 pg/ml. bation step with the polymer-HRP detection kit QD420-Histological Analysis YIK (BioGenex) followed by 3,3′-diaminobenzidine detection. Slides were counterstained with hematoxylin. Formalin-fixed vascular grafts were embedded in paraffin, cross-sectioned, deparaffinized, rehydrated, and
Statistical Analysis subjected to hematoxylin and eosin (H&E) or orcein staining. Intimal hyperplasia of vascular grafts was All data are expressed as mean ± SD. Statistical analysis was performed using the Mann-Whitney test or Stu-determined from the computer images of orcein-stained cross sections. The area surrounded by internal elastic dent t-test for continuous variables and chi-square analysis for categorical variables, respectively. Values lamina (IELA) and the luminal area (LA) were calculated by an image analysis program (NIH Image). The of p < 0.05 were considered statistically significant. 
RESULTS
and 2D,a). MSC treatment resulted in a significant reduction of cell infiltration (Fig. 2C,c and 2D,a) . Immu-Characterization of Porcine MSCs nohistochemical analysis showed that a vast majority of Cells were isolated from porcine BM and selected the infiltrating cells in the untreated allografts were based on their adherence to plastic. After 7 days of cul-CD3 + lymphocytes that were significantly reduced by ture, the adherent cells had a spindle-like appearance MSC treatment (Fig. 2C,e vs. 2C,f, and 2D,b). These (Fig. 1A,a) . FACS analysis revealed that these BMresults indicate that autologous MSCs prevent TA by derived cells were negative for hematopoietic cell markattenuating alloantigen-induced inflammatory reactions ers CD11R3, CD34, and CD45, positive for the cell and intimal hyperplasia. adhesion molecule CD44, progenitor cell markers MSCs Protect the Long-Term Patency CD90, and CD105, and MHC class I but not MHC class of Transplanted Vessels II (Fig. 1B) . They were able to differentiate into osteocytes, chondrocytes, and adipocytes (Fig. 1A,b-d ). Both
The long-term effects of MSCs on arterial grafts were evaluated by serial angiographic examinations up to 12 MSCs and their conditioned medium were able to suppress proliferation of allogeneic peripheral mononuclear weeks. The results revealed patent anastomoses in all autografts (n = 8) throughout the study period of 12 cells in MLRs (Fig. 1C) . Taken together, the characteristics of our cells fulfill the recommended definition of weeks (Fig. 3A, B ). On the contrary, only 58% (7/12) of the allografts in the control group were patent at the MSCs for their application to the immunomodulation therapy of solid organ transplantation (7) .
4th week and all of them became occluded by the end of the 8th week posttransplantation (Fig. 3A, B ). Nota-MSCs Attenuate Neointima Formation bly, MSC treatment significantly improved vascular patin Transplanted Vessels ency. Up to 83% (10/12) of the MSC-treated allografts remained patent 12 weeks after transplantation (p < We investigated the immunosuppressive effect of autologous MSCs on TA in a porcine model of femoral 0.001 between untreated and MSC-treated allografts) ( Fig. 3A, B ). artery transplantation. To assess the intimal hyperplasia in the early stage of TA (16), we performed IVUS exam-Histological examination of the vascular grafts at the time of occlusion or at the study end point (12 weeks ination 4 weeks after transplantation. As shown in Figure 2A , intimal hyperplasia was observed diffusely after transplantation) confirmed the angiographic findings ( Fig. 4A ). Compared to autografts, the untreated along the untreated allograft but not in the autograft, indicating that the neointimal formation was resulted allograft was completely occluded by intimal hyperplasia, which was enriched with α-SMA-positive smooth from allogeneic transplantation but not surgical injury. Intimal hyperplasia was not evident in the MSC-treated muscle cells and possibly myofibroblasts (Fig. 4A, B) . The histological findings of the untreated allograft are allografts. The extent of maximum area stenosis in the MSC-treated allografts was significantly lower than that consistent with the vascular changes of human TA. The intimal hyperplasia of the allograft was significantly in the untreated allografts at 4 weeks postarterial transplantation (18 ± 6% vs. 40 ± 12%, p < 0.001) (Fig. 2B) . attenuated by MSC treatment (Fig. 4B) , as were the excessive α-SMA-positive cells (Fig. 4A) . These find-Histological examinations revealed increased cell infiltration in the intimal and perivascular regions of the ings indicate that locally delivered MSCs not only suppress TA in the early stage posttransplantation, but also untreated allograft versus autograft (Fig. 2C,b vs. 2C,a, improve long-term graft patency rate by controlling inti-data, our findings imply that MSCs situated adjacent to the transplant may produce soluble factors that suppress mal hyperplasia.
immune cell proliferation. In agreement with previous Localization of MSCs in the Tissue of Recipients reports (1, 9, 23) , our results show that the MSC conditioned medium suppresses proliferation of allogeneic To track the injected SPIO-loaded MSCs in vivo, we did serial MRI scanning of MSC-treated allografts from mononuclear cells. Since the locally injected MSCs remain detectable at 12 weeks after transplantation, it is 3 days to 12 weeks after transplantation. As shown in Figure 5A , most SPIO particles were localized to the reasonable to speculate that MSCs prolong vascular allograft patency via the sustained secretion of soluble factors. soft tissue adjacent to the vascular grafts. Histological examinations at 4 or 12 weeks after transplantation It is controversial whether the immunomodulatory effects of MSCs depend on their MHC genotypes. Previ-revealed localization of the SPIO-loaded cells to the vascular adventitia (Fig. 5B ) and in skeletal muscle sur-ous studies in rodent models showed that only MSCs derived from the donor or a third party that partially rounding the vascular grafts (Fig. 5C ).
shared MHC with the donor are effective in induction Expression of Immune Modulatory Factors of tolerance to cardiac allografts (5, 20) . However, other in the Vascular Grafts studies claimed that infusion of MSCs, derived from either the recipient or a third party, could achieve long-To determine whether Treg expansion was involved in MSC-induced allograft tolerance, we analyzed Foxp3 term graft tolerance (11). In the present study, we demonstrate the protective effects of autologous MSCs. Our mRNA expression by real-time quantitative PCR in untreated allografts harvested at the time when vascular finding is supported by the recent report that systemic infusion of syngeneic crude BM mononuclear cells pro-occlusion was noted and in MSC-treated allografts and autografts harvested 12 weeks after transplantation.
tected aortic allografts from intimal hyperplasia in rats (10). These results have important clinical implications. Compared to autografts, Foxp3 expression levels were increased in both untreated (5.0 ± 3.2 fold) and MSC-
The recipient autologous BM-derived MSCs are much more convenient to procure than the MSCs from the treated (6.5 ± 2.8 fold) allografts, and there was no significant difference between these two groups (p = donor or a third party. Furthermore, the allogeneic MSCs may not be entirely immunoprivileged (2, 5, 20) . 0.310). By contrast, IL-10, IFN-γ, and IDO were significantly higher in the MSC-treated allografts than in the Recent studies have suggested a role of Tregs in MSC-mediated immunosuppression (5, 11) . In our pig untreated allografts (p = 0.021 for IL-10, p = 0.003 for IFN-γ, and p = 0.008 for IDO) (Fig. 6A ), whereas HGF model of femoral artery transplantation, IL-10 was found to be more abundant in MSC-treated allografts and TGF-β1 were not different (data not shown). To determine whether IL-10 and IFN-γ are elevated in cir-than in the untreated ones ( Fig. 6A ). However, the expression levels of Foxp3 mRNA were comparable culation, we measured their serum protein levels by ELISA. Neither cytokine was detectable in any of the between these two groups. These results suggest that the inducible type 1 regulatory T (Tr1)-like cells, instead of experimental groups, suggesting that they are increased locally by MSC treatment.
the naturally occurring Foxp3 + Tregs, are involved in MSC-induced allograft tolerance. Tr1-like cells are Immunohistochemical analysis of the MSC-treated allograft revealed that IL-10 and IFN-γ expressions were chronically activated by persistent antigens, produce large amounts of IL-10 and IFN-γ, and are able to sup-increased mostly in the perivascular cells while IDO expression was diffusely distributed extending from the press antigen-specific immune responses both in vitro and in vivo (12, 13, 28) . Interestingly, in addition to IL-intimal to the perivascular region (Fig. 6B) .
10, IFN-γ expression was significantly increased in DISCUSSION MSC-treated vascular allografts compared to untreated controls in our animal model. Furthermore, both cyto-Our findings indicate that local injection of autologous MSCs alone at the time of femoral artery transplan-kines are localized to the infiltrating mononuclear cells at the perivascular site. It remains to be confirmed that tation is effective in preventing TA in a porcine model. The beneficial effect is attributed to the immunosuppres-the infiltrating cells are Trl-like cells. IFN-γ is generally considered as a proatherogenic sive action of MSCs. The exact mechanism underlying the immunosuppressive effect of MSCs is not entirely factor in TA (18, 22, 25) . However, in the immune system inflammation frequently elicits counterregulatory clear. Our results suggest that MSCs act in situ to exert immunosuppressive activities through paracrine actions.
(anti-inflammatory) pathways. Recent studies have shown that IFN-γ might help limit excessive T-cell acti-We show by serial MRI tracking and histological analysis that the injected MSCs are retained at the sites adja-vation at local sites of inflammation through the induction of IDO expression (4, 8) . Our immunohistochemistry cent to the vascular transplants. Based on the in vivo , and indoleamine 2,3-dioxygenase (IDO) in untreated (n = 10) or MSC-treated (n = 10) allografts relative to autografts by realtime quantitative PCR analysis. Grafts were harvested once found to be occluded on angiograms or at the end of the study (12 weeks posttransplantation). Data are presented as box plots: the boundaries of a box indicate the 25th and 75th percentiles, the line within a box marks the median, and whiskers above and below a box indicate the 90th and 10th percentiles. *p = 0.021 for IL-10, p = 0.003 for IFN-γ, and p = 0.008 for IDO. (B) Immunohistochemical staining of the MSC-treated allografts harvested 12 weeks posttransplantation using antibodies to IL-10 (a, d), IFN-γ (b, e), and IDO (c, f). The inset in (c) is the matched isotype control.
Lumen is oriented toward the bottom right corner on each image. Black and white arrows mark the internal and external elastic laminae, respectively. Scale bars: 100 µm for all panels. analysis provides evidence for increased IFN-γ expres-Taken together, IFN-γ-mediated IDO expression within the local environment of the transplant could indeed pro-sion by MSC treatment in the perivascular mononuclear cells accompanied by elevation of IDO expression pri-long graft survival by inducing immunological tolerance.
In conclusion, our results provide strong evidence for marily in the medial layer. These findings are in keeping with the recent report that IFN-γ-induced IDO expres-controlling allograft intimal hyperplasia and maintaining vascular patency by MSCs through an IFN-γ-IDO mecha-sion in human vascular smooth muscle cells inhibits allogeneic T-cell response in vitro and in vivo (6) . More nism. We postulate that MSCs stimulate the Trl-like cells that express IL-10 and IFN-γ, and IFN-γ in turn induces importantly, blocking of IDO with 1-methyl tryptophan was reported to abrogate MSC-induced long-term graft IDO expression in the vascular smooth muscle cells. Through the immunosuppressing actions of these mole-acceptance in a rat heart transplantation model (20).
